Literature DB >> 21132002

Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells.

S Ehata1, E Johansson, R Katayama, S Koike, A Watanabe, Y Hoshino, Y Katsuno, A Komuro, D Koinuma, M R Kano, M Yashiro, K Hirakawa, H Aburatani, N Fujita, K Miyazono.   

Abstract

Stem cells in normal tissues and cancer-initiating cells (CICs) are known to be enriched in side population (SP) cells. However, the factors responsible for the regulation of expression of ABCG2, involved in efflux of dyes, in SP cells have not been fully investigated. Here, we characterized the SP cells within diffuse-type gastric carcinoma, and examined the effects of transforming growth factor-β (TGF-β) on SP cells. Diffuse-type gastric carcinoma cells established from four independent patients universally contained SP cells between 1 and 4% of total cells, which displayed greater tumorigenicity than non-SP cells did. TGF-β repressed the transcription of ABCG2 through direct binding of Smad2/3 to its promoter/enhancer, and the number of SP cells and the tumor-forming ability of cancer cells were decreased by TGF-β, although ABCG2 is not directly involved in the tumor-forming ability of SP cells. Cancer cells from metastatic site expressed much higher levels of ABCG2 and included a greater percentage of SP cells than parental cancer cells did. SP cells are thus responsible for the progression of diffuse-type gastric carcinoma, and TGF-β negatively contributes to maintain the CICs within the cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21132002     DOI: 10.1038/onc.2010.546

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

1.  Prostate cancer cells and bone stromal cells mutually interact with each other through bone morphogenetic protein-mediated signals.

Authors:  Hikaru Nishimori; Shogo Ehata; Hiroshi I Suzuki; Yoko Katsuno; Kohei Miyazono
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

2.  Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftment.

Authors:  Hua Jiang; Xiaolong Lin; Yingtao Liu; Wenjia Gong; Xiaoling Ma; Yinhua Yu; Yi Xie; Xiaoxi Sun; Youji Feng; Viktor Janzen; Tong Chen
Journal:  Mol Med       Date:  2012-10-24       Impact factor: 6.354

Review 3.  Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

Authors:  Karthika Natarajan; Yi Xie; Maria R Baer; Douglas D Ross
Journal:  Biochem Pharmacol       Date:  2012-01-11       Impact factor: 5.858

Review 4.  Targeting TGF-β Signaling for Therapeutic Gain.

Authors:  Rosemary J Akhurst
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-10-03       Impact factor: 10.005

5.  Transforming growth factor-β decreases side population cells in hepatocellular carcinoma in vitro.

Authors:  Jong Bin Kim; Seulki Lee; Hye Ri Kim; Seo-Young Park; Minjong Lee; Jung-Hwan Yoon; Yoon Jun Kim
Journal:  Oncol Lett       Date:  2018-04-05       Impact factor: 2.967

Review 6.  Cancer stem cell theory in gastrointestinal malignancies: recent progress and upcoming challenges.

Authors:  Dyah Laksmi Dewi; Hideshi Ishii; Yoshihiro Kano; Shinpei Nishikawa; Naotsugu Haraguchi; Daisuke Sakai; Taroh Satoh; Yuichiro Doki; Masaki Mori
Journal:  J Gastroenterol       Date:  2011-08-20       Impact factor: 7.527

7.  Expression pattern of polypeptide N-acetylgalactosaminyltransferase-10 in gastric carcinoma.

Authors:  Yuan Gao; Zhenhua Liu; Jinghua Feng; Qizhe Sun; Bao Zhang; Wenling Zheng; Wenli Ma
Journal:  Oncol Lett       Date:  2012-10-19       Impact factor: 2.967

Review 8.  Gastric cancer stem cells: a novel therapeutic target.

Authors:  Shree Ram Singh
Journal:  Cancer Lett       Date:  2013-04-10       Impact factor: 8.679

9.  Epigenetic silencing of GDF1 disrupts SMAD signaling to reinforce gastric cancer development.

Authors:  W Yang; M T S Mok; M S M Li; W Kang; H Wang; A W Chan; J-L Chou; J Chen; E K W Ng; K-F To; J Yu; M W Y Chan; F K L Chan; J J Y Sung; A S L Cheng
Journal:  Oncogene       Date:  2015-07-27       Impact factor: 9.867

Review 10.  Targeting the TGFβ signalling pathway in disease.

Authors:  Rosemary J Akhurst; Akiko Hata
Journal:  Nat Rev Drug Discov       Date:  2012-09-24       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.